✦ LIBER ✦

Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: A systematic review with meta-analysis

✍ Scribed by João Paulo da Silveira Nogueira Lima; Lucas Vieira dos Santos; Emma Chen Sasse; Andre Deeke Sasse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy with cetuximab or chemother

✍ Lin, Hao; Jiang, Jingwei; Liang, Xiaohua; Zhou, XinLi; Huang, Ruofan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Postoperative chemotherapy for non–small

✍ Artyom Sedrakyan; Jan van Der Meulen; Ken O'Byrne; Joseph Prendiville; Jennifer 📂 Article 📅 2004 🏛 CTSNet 🌐 English ⚖ 253 KB

Second-line treatment for advanced non-s

✍ Barlési, Fabrice; Jacot, William; Astoul, Philippe; Pujol, Jean-Louis 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Doublet Versus Single Cytotoxic Agent as

✍ Qi, Wei-Xiang; Tang, Li-na; He, Ai-na; Shen, Zan; Lin, Feng; Yao, Yang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 465 KB

Taxanes as first-line therapy for advanc

✍ Chu, Quincy; Vincent, Mark; Logan, Diane; Mackay, Jean A.; Evans, William K. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Beyond Doublet Chemotherapy for Advanced

✍ Roy S. Herbst; Thomas J. Lynch; Alan B. Sandler 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB